iTonic Holdings Ltd ITOC
Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2024 · data as of November 13, 2026
iTonic Holdings Ltd (ITOC) is a healthcare company listed in the US with a market value of about $14M. In fiscal year 2025 it had revenue of $523031 and net income of -$5M, a net margin of -974.7%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -34%.
About iTonic Holdings
iTonic Holdings is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2024. Revenue went from $679777 in 2022 to $523031 in 2025, a decline of about 8.4% a year. It was profitable in 1 of the last 4 years in our data. It spends 88% of revenue on research and development.
Score: 1.4 / 5
Checks passed
- Revenue growth above 10% last year
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Liabilities below 60% of assets
- Pays a dividend
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 4 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $523031 | $448196 | $628591 | $679777 |
| Net income | -$5M | -$660588 | -$241217 | $83980 |
| Free cash flow | -$3M | -$775861 | — | — |
| EPS (diluted) | $-0.70 | $-0.09 | $-0.03 | $0.01 |
| Net margin | -974.7% | -147.4% | -38.4% | 12.3% |
| ROIC | -66.9% | -9.8% | -61.5% | 3.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does iTonic Holdings pay a dividend?
Yes. The dividend yield is about 0.06%, and it has paid dividends for 2 years in our data.
Is iTonic Holdings a good stock to buy?
We do not give buy or sell advice. iTonic Holdings scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.